Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zangdi Babao Tablets is a Traditional Chinese Medicine (TCM) or Tibetan medicine formulation primarily indicated for the treatment of male infertility and the improvement of sperm quality. The product is a multi-ingredient herbal preparation, typically incorporating traditional tonics such as *Cordyceps sinensis*, *Saussurea involucrata* (Snow Lotus), and *Crocus sativus* (Saffron), which are traditionally believed to tonify the kidney and replenish reproductive essence. It is currently being evaluated in a Phase 4 clinical trial (ChiCTR2500108085) in China to assess its efficacy and safety in improving sperm progressive motility and other reproductive parameters in men with infertility due to poor sperm quality over a 12-week treatment period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zangdi Babao Tablets.